companydata.dkFLUIMEDIX ApS: Financial statements 2024
CVR: 27021689
FLUIMEDIX ApS (CVR 27021689) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -56,321 and a net result of DKK -64,901 compared with DKK -80,655 the year before. Equity amounted to DKK 237,871. The solvency ratio was 73.5%. The company had 1 employee in the financial year.
- Gross Profit
- -56,321 kr.
- Profit/Loss
- -64,901 kr.
- Equity
- 237,871 kr.
- Total Assets
- 323,816 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -56 t. | -65 t. | 238 t. | 1 |
| 2023 | - | 244 t. | -81 t. | 303 t. | 1 |
| 2022 | - | -89 t. | -364 t. | 383 t. | 1 |
| 2021 | - | -1 t. | -279 t. | 747 t. | 1 |
| 2020 | - | -182 t. | -254 t. | 1 mio. | - |
How creditworthy is FLUIMEDIX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
FLUIMEDIX ApS has published its annual report for 2023. Gross profit came to DKK 244,180, and the net result was DKK -80,655.
About FLUIMEDIX ApS
FLUIMEDIX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2003. The company is registered under the industry Anden teknisk rådgivning. The management consists of Tomas Ussing. The company is owned by OPFINDER HOLDING AF 2003 ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 12,224 and a net result of DKK 17,955 compared with DKK -64,901 the year before. Equity amounted to DKK 255,826.